Kidney International, ISSN 0085-2538, 07/2017, Volume 92, Issue 1, pp. 26 - 36
The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the...
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism | UROLOGY & NEPHROLOGY | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Humans | Risk Factors | Treatment Outcome | Nephrology - standards | Biomarkers - blood | Parathyroid Hormone - blood | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Bone Remodeling - drug effects | Consensus | Evidence-Based Medicine - standards | Vitamin D - adverse effects | Calcium - blood | Phosphates - blood | Dietary Supplements - adverse effects | Vitamin D - therapeutic use | Chelating Agents - therapeutic use | Chelating Agents - adverse effects
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism | UROLOGY & NEPHROLOGY | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Humans | Risk Factors | Treatment Outcome | Nephrology - standards | Biomarkers - blood | Parathyroid Hormone - blood | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Bone Remodeling - drug effects | Consensus | Evidence-Based Medicine - standards | Vitamin D - adverse effects | Calcium - blood | Phosphates - blood | Dietary Supplements - adverse effects | Vitamin D - therapeutic use | Chelating Agents - therapeutic use | Chelating Agents - adverse effects
Journal Article
Kidney International, ISSN 0085-2538, 07/2017, Volume 92, Issue 1, pp. 26 - 36
The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the...
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism
Journal Article
Clinical Kidney Journal, ISSN 2048-8505, 02/2018, Volume 11, Issue 1, pp. 70 - 72
Patients with chronic kidney disease (CKD) are affected by mineral and bone disorder (MBD), resulting in abnormalities in serum calcium (Ca), phosphorous (P)...
KDIGO | CKD-MBD | Secondary hyperparathyroidism | KIDNEY-DISEASE | PHOSPHORUS | secondary hyperparathyroidism | MORTALITY RISK | PHOSPHATE PRODUCT | ACHIEVEMENT | DIALYSIS PATIENTS | CALCIUM | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | BONE | CKD Complications
KDIGO | CKD-MBD | Secondary hyperparathyroidism | KIDNEY-DISEASE | PHOSPHORUS | secondary hyperparathyroidism | MORTALITY RISK | PHOSPHATE PRODUCT | ACHIEVEMENT | DIALYSIS PATIENTS | CALCIUM | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | BONE | CKD Complications
Journal Article
Kidney International Reports, ISSN 2468-0249, 11/2019, Volume 4, Issue 11, pp. 1523 - 1537
Improving Global Outcomes (KDIGO) Clinical Practice Guideline on Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD) 2009 provided recommendations on...
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | hyperparathyroidism | CKD | MORTALITY | PHOSPHORUS | MANAGEMENT | FRACTURE RISK | OSTEOPOROSIS | DENSITY | INDIVIDUALS | METABOLISM | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY
dialysis | bone mineral density | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | hyperparathyroidism | CKD | MORTALITY | PHOSPHORUS | MANAGEMENT | FRACTURE RISK | OSTEOPOROSIS | DENSITY | INDIVIDUALS | METABOLISM | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2010, Volume 55, Issue 5, pp. 773 - 799
This commentary provides a US perspective on the 2009 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for the Diagnosis,...
Nephrology | chronic kidney disease | Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney Disease Outcomes Quality Initiative (KDOQI) | Clinical practice guideline | guideline adaptation | renal osteodystrophy | mineral and bone disease | VITAMIN-D | ALKALINE-PHOSPHATASE | MORTALITY RISK | X PHOSPHATE PRODUCT | ESRD PAYMENT PERSPECTIVES | PROPOSED RULE | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | Monitoring, Physiologic - standards | United States | Humans | Hypercalcemia - therapy | Medicare - economics | Renal Dialysis - economics | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - therapy | Reimbursement Mechanisms | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Hyperphosphatemia - therapy | Renal Insufficiency, Chronic - economics | Bone Diseases, Metabolic - therapy | Phosphate-Binding Proteins - administration & dosage | Renal Insufficiency, Chronic - classification | Chronic Kidney Disease-Mineral and Bone Disorder - therapy | Global Health | Bone Diseases, Metabolic - prevention & control | Bone Diseases, Metabolic - diagnosis | Bone Diseases, Metabolic - etiology | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Calcinosis | Hyperphosphatemia - etiology | Hypercalcemia - etiology | Practice Guidelines as Topic
Nephrology | chronic kidney disease | Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney Disease Outcomes Quality Initiative (KDOQI) | Clinical practice guideline | guideline adaptation | renal osteodystrophy | mineral and bone disease | VITAMIN-D | ALKALINE-PHOSPHATASE | MORTALITY RISK | X PHOSPHATE PRODUCT | ESRD PAYMENT PERSPECTIVES | PROPOSED RULE | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | Monitoring, Physiologic - standards | United States | Humans | Hypercalcemia - therapy | Medicare - economics | Renal Dialysis - economics | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - therapy | Reimbursement Mechanisms | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Hyperphosphatemia - therapy | Renal Insufficiency, Chronic - economics | Bone Diseases, Metabolic - therapy | Phosphate-Binding Proteins - administration & dosage | Renal Insufficiency, Chronic - classification | Chronic Kidney Disease-Mineral and Bone Disorder - therapy | Global Health | Bone Diseases, Metabolic - prevention & control | Bone Diseases, Metabolic - diagnosis | Bone Diseases, Metabolic - etiology | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Calcinosis | Hyperphosphatemia - etiology | Hypercalcemia - etiology | Practice Guidelines as Topic
Journal Article
07/2017, Volume 92, Issue 1
The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the...
dialysis | bone mineral density | Nephrology | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism
dialysis | bone mineral density | Nephrology | calcium | hyperphosphatemia | KDIGO CKD-MBD Guideline | kidney transplantation | hyperparathyroidism
Publication
Kidney International Supplements, ISSN 2157-1716, 07/2017, Volume 7, Issue 1, pp. 1 - 59
The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of...
chronic kidney disease | kidney transplantation | CINACALCET HCL THERAPY | SECONDARY HYPERPARATHYROIDISM | DOSE VITAMIN-D | hyperparathyroidism | CKD-MBD | bone mineral density | CORONARY-ARTERY CALCIFICATION | hyperphosphatemia | phosphorus | dialysis | EARLY CORTICOSTEROID WITHDRAWAL | parathyroid hormone | calcium | SERUM PARATHYROID-HORMONE | mineral and bone disorder | phosphate | YOUNG-ADULT MEN | systematic review | PATIENTS RECEIVING HEMODIALYSIS | CALCIUM-CARBONATE | bone abnormalities | guideline | KDIGO | UROLOGY & NEPHROLOGY | STAGE RENAL-DISEASE
chronic kidney disease | kidney transplantation | CINACALCET HCL THERAPY | SECONDARY HYPERPARATHYROIDISM | DOSE VITAMIN-D | hyperparathyroidism | CKD-MBD | bone mineral density | CORONARY-ARTERY CALCIFICATION | hyperphosphatemia | phosphorus | dialysis | EARLY CORTICOSTEROID WITHDRAWAL | parathyroid hormone | calcium | SERUM PARATHYROID-HORMONE | mineral and bone disorder | phosphate | YOUNG-ADULT MEN | systematic review | PATIENTS RECEIVING HEMODIALYSIS | CALCIUM-CARBONATE | bone abnormalities | guideline | KDIGO | UROLOGY & NEPHROLOGY | STAGE RENAL-DISEASE
Journal Article
Renal Replacement Therapy, ISSN 2059-1381, 12/2018, Volume 4, Issue 1, pp. 1 - 5
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and outcomes of kidney disease patients worldwide through the...
KDIGO | Survival | CKD | Clinical practice guideline | CKD-MBD
KDIGO | Survival | CKD | Clinical practice guideline | CKD-MBD
Journal Article
Osteologicky Bulletin, ISSN 1211-3778, 2012, Volume 17, Issue 1, pp. 14 - 20
Journal Article
Clinical Kidney Journal, ISSN 2048-8505, 10/2018, Volume 11, Issue 5, pp. 710 - 719
Background. The aim of the third French Phosphorus and Calcium Observatory (Photo-Graphe (R) 3) was to assess the achievement of international Kidney Disease:...
KDIGO | phosphate | chronic kidney disease | calcium | survival | MORTALITY | CARDIOVASCULAR EVENTS | RISK | GUIDELINE | METABOLISM | UROLOGY & NEPHROLOGY | HEMODIALYSIS | ASSOCIATION | EPIDEMIOLOGY | CKD-Mbd
KDIGO | phosphate | chronic kidney disease | calcium | survival | MORTALITY | CARDIOVASCULAR EVENTS | RISK | GUIDELINE | METABOLISM | UROLOGY & NEPHROLOGY | HEMODIALYSIS | ASSOCIATION | EPIDEMIOLOGY | CKD-Mbd
Journal Article
NEPHROLOGIE & THERAPEUTIQUE, ISSN 1769-7255, 06/2010, Volume 6, Issue 3, pp. 151 - 157
The new recommendations of "Kidney disease: improving global outcomes" for the definition and classification of chronic kidney disease and mineral and bone...
VITAMIN-D | TURNOVER | BIOCHEMICAL MARKERS | MORTALITY RISK | VASCULAR CALCIFICATION | Chronic kidney disease | KDOQI | DENSITY | Mineral and bone disorders | DIALYSIS PATIENTS | CALCIUM | KDIGO | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | RENAL OSTEODYSTROPHY | Bone Diseases - etiology | Calcium Metabolism Disorders - prevention & control | Calcium Metabolism Disorders - etiology | Humans | Phosphorus Metabolism Disorders - etiology | Bone Diseases - prevention & control | Kidney Diseases - complications | France | Chronic Disease | Phosphorus Metabolism Disorders - prevention & control | Practice Guidelines as Topic
VITAMIN-D | TURNOVER | BIOCHEMICAL MARKERS | MORTALITY RISK | VASCULAR CALCIFICATION | Chronic kidney disease | KDOQI | DENSITY | Mineral and bone disorders | DIALYSIS PATIENTS | CALCIUM | KDIGO | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | RENAL OSTEODYSTROPHY | Bone Diseases - etiology | Calcium Metabolism Disorders - prevention & control | Calcium Metabolism Disorders - etiology | Humans | Phosphorus Metabolism Disorders - etiology | Bone Diseases - prevention & control | Kidney Diseases - complications | France | Chronic Disease | Phosphorus Metabolism Disorders - prevention & control | Practice Guidelines as Topic
Journal Article
Nephron, ISSN 1660-8151, 03/2016, Volume 132, Issue 3, pp. 168 - 174
Background: Increased mortality of hemodialysis (HD) patients is associated with chronic kidney disease-mineral and bone disorders (CKD-MBD), and therefore,...
Clinical Practice: Original Paper | KDIGO | Patient outcome | Serbia | KDOQI | Mineral bone disorders | SURVIVAL | PHOSPHORUS | MORTALITY RISK | DEATH | ACHIEVEMENT | SERUM-CALCIUM | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | CHRONIC KIDNEY-DISEASE | PRACTICE PATTERNS | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - metabolism | Calcium - blood | Renal Insufficiency, Chronic - therapy | Guideline Adherence | Renal Dialysis - mortality | Phosphorus - blood | Bone and Bones - metabolism | Renal Insufficiency, Chronic - mortality | Adult | Female | Aged | Goals | Serbia - epidemiology
Clinical Practice: Original Paper | KDIGO | Patient outcome | Serbia | KDOQI | Mineral bone disorders | SURVIVAL | PHOSPHORUS | MORTALITY RISK | DEATH | ACHIEVEMENT | SERUM-CALCIUM | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | CHRONIC KIDNEY-DISEASE | PRACTICE PATTERNS | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - metabolism | Calcium - blood | Renal Insufficiency, Chronic - therapy | Guideline Adherence | Renal Dialysis - mortality | Phosphorus - blood | Bone and Bones - metabolism | Renal Insufficiency, Chronic - mortality | Adult | Female | Aged | Goals | Serbia - epidemiology
Journal Article
Clinical Laboratory, ISSN 1433-6510, 2012, Volume 58, Issue 7-8, pp. 719 - 724
Secondary hyperparathyroidism develops frequently with chronic kidney disease (CKD) and is associated with poor outcome. The new CKD-MBD guideline, Kidney...
KDIGO | PTH assays | KDOQI | Secondary hyperparathyroidism | Kidney Failure, Chronic - classification | Guidelines as Topic | Parathyroid Hormone - blood | Kidney Failure, Chronic - blood | Humans
KDIGO | PTH assays | KDOQI | Secondary hyperparathyroidism | Kidney Failure, Chronic - classification | Guidelines as Topic | Parathyroid Hormone - blood | Kidney Failure, Chronic - blood | Humans
Journal Article
CLINICAL LABORATORY, ISSN 1433-6510, 2012, Volume 58, Issue 7-8, pp. 719 - 724
Background: Secondary hyperparathyroidism develops frequently with chronic kidney disease (CKD) and is associated with poor outcome. The new CKD-MBD guideline,...
PTH assays | secondary hyperparathyroidism | VASCULAR CALCIFICATION | KDIGO | HEMODIALYSIS-PATIENTS | SERUM | MEDICAL LABORATORY TECHNOLOGY | KDOQI
PTH assays | secondary hyperparathyroidism | VASCULAR CALCIFICATION | KDIGO | HEMODIALYSIS-PATIENTS | SERUM | MEDICAL LABORATORY TECHNOLOGY | KDOQI
Journal Article
Bone, ISSN 8756-3282, 2011, Volume 49, Issue 1, pp. 77 - 81
Abstract Bisphosphonates are eliminated from the human body by the kidney. Renal clearance is both by glomerular filtration and proximal tubular secretion....
Orthopedics | Chronic kidney disease-mineral and bone disorder (CKD-MBD) | Osteoporosis | Renal | Bisphosphonates | Kidney | POSITION STATEMENT | RENAL-FUNCTION | ZOLEDRONIC ACID | SERUM CREATININE | HIP FRACTURE | DISEASE | ENDOCRINOLOGY & METABOLISM | GLOBAL OUTCOMES KDIGO | POSTMENOPAUSAL WOMEN | CREATININE CLEARANCE | Animals | Kidney - drug effects | Kidney - pathology | Humans | Diphosphonates - pharmacokinetics | Diphosphonates - therapeutic use | Osteoporosis - drug therapy | Diphosphonates - adverse effects | Osteoporosis - physiopathology | Diphosphonates - pharmacology | Kidney - physiopathology | Kidney Function Tests
Orthopedics | Chronic kidney disease-mineral and bone disorder (CKD-MBD) | Osteoporosis | Renal | Bisphosphonates | Kidney | POSITION STATEMENT | RENAL-FUNCTION | ZOLEDRONIC ACID | SERUM CREATININE | HIP FRACTURE | DISEASE | ENDOCRINOLOGY & METABOLISM | GLOBAL OUTCOMES KDIGO | POSTMENOPAUSAL WOMEN | CREATININE CLEARANCE | Animals | Kidney - drug effects | Kidney - pathology | Humans | Diphosphonates - pharmacokinetics | Diphosphonates - therapeutic use | Osteoporosis - drug therapy | Diphosphonates - adverse effects | Osteoporosis - physiopathology | Diphosphonates - pharmacology | Kidney - physiopathology | Kidney Function Tests
Journal Article
NEPHROLOGIE & THERAPEUTIQUE, ISSN 1769-7255, 06/2010, Volume 6, Issue 3, pp. 149 - 150
UROLOGY & NEPHROLOGY | KDIGO guideline | Mineral and bone disorder | CKD | Bone Diseases - etiology | Calcium Metabolism Disorders - prevention & control | Calcium Metabolism Disorders - etiology | Humans | Phosphorus Metabolism Disorders - etiology | Bone Diseases - prevention & control | Kidney Diseases - complications | Chronic Disease | Phosphorus Metabolism Disorders - prevention & control | Practice Guidelines as Topic
Journal Article
Nephrology, ISSN 1320-5358, 06/2010, Volume 15, Issue 2, pp. 43 - 44
ABSTRACT By establishing Kidney Diseases: Improving Global Outcome (KDIGO), nephrology has taken an important step towards developing global clinical practice...
KDIGO | guidelines | Asia | CKD | Guidelines | UROLOGY & NEPHROLOGY | Kidney Failure, Chronic - therapy | Morbidity - trends | Asia - epidemiology | Kidney Failure, Chronic - epidemiology | Practice Guidelines as Topic - standards | Humans | Outcome Assessment (Health Care) - standards | Transplantation of organs, tissues, etc | Practice guidelines (Medicine) | Kidney diseases | Hepatitis C
KDIGO | guidelines | Asia | CKD | Guidelines | UROLOGY & NEPHROLOGY | Kidney Failure, Chronic - therapy | Morbidity - trends | Asia - epidemiology | Kidney Failure, Chronic - epidemiology | Practice Guidelines as Topic - standards | Humans | Outcome Assessment (Health Care) - standards | Transplantation of organs, tissues, etc | Practice guidelines (Medicine) | Kidney diseases | Hepatitis C
Journal Article
Indian Journal of Nephrology, ISSN 0971-4065, 07/2011, Volume 21, Issue 3, pp. 143 - 151
THIS COMMENTARY PRESENTS THE VIEW OF AN EXPERT GROUP OF INDIAN NEPHROLOGISTS ON ADAPTATION AND IMPLEMENTATION OF THE KIDNEY DISEASE: Improving Global Outcomes...
KDIGO | Chronic kidney disease | hyperparathyroidism | mineral and bone disorder | guideline | Usage | Care and treatment | Chronic kidney failure | Practice guidelines (Medicine) | Bone diseases | Research | Diagnosis | Nephrology | Kidney diseases | Clinical medicine | Medical diagnosis | Medical treatment
KDIGO | Chronic kidney disease | hyperparathyroidism | mineral and bone disorder | guideline | Usage | Care and treatment | Chronic kidney failure | Practice guidelines (Medicine) | Bone diseases | Research | Diagnosis | Nephrology | Kidney diseases | Clinical medicine | Medical diagnosis | Medical treatment
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2010, Volume 55, Issue 5, pp. 941 - 956
Osteoporosis and chronic kidney disease (CKD) are both common conditions of older adults and both may be associated with substantial morbidity. However,...
Nephrology | bisphosphonates | Kidney Disease: Improving Global Outcomes (KDIGO) | pharmacologic treatment | Metabolic bone disease | BONE-MINERAL DENSITY | RENAL-FUNCTION | CALCIUM SUPPLEMENTATION | NANDROLONE DECANOATE | UROLOGY & NEPHROLOGY | QUANTITATIVE ULTRASOUND | CHRONIC KIDNEY-DISEASE | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | POSTMENOPAUSAL WOMEN | ESTABLISHED OSTEOPOROSIS | Life Style | Raloxifene Hydrochloride - therapeutic use | Teriparatide - therapeutic use | Bone Density - physiology | Osteoporosis - therapy | Humans | Vitamin D Deficiency - drug therapy | Tomography, X-Ray Computed - methods | Calcitonin - therapeutic use | Parathyroid Hormone - blood | Vitamin D Deficiency - physiopathology | Glomerular Filtration Rate - physiology | Calcitonin - administration & dosage | Renal Insufficiency, Chronic - epidemiology | Accidental Falls - prevention & control | Selective Estrogen Receptor Modulators - therapeutic use | Nandrolone - therapeutic use | Diphosphonates - therapeutic use | Phosphates - blood | Female | Osteoporosis - physiopathology | Osteoporosis - epidemiology | Parathyroid Hormone - physiology | Teriparatide - administration & dosage | Comorbidity | Nandrolone - administration & dosage | Nandrolone - analogs & derivatives | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - administration & dosage | Nitric Oxide - administration & dosage | Absorptiometry, Photon | Renal Insufficiency, Chronic - physiopathology | Magnetic Resonance Imaging | Animals | Vitamin D Deficiency - epidemiology | Aged | Muscle Strength - physiology
Nephrology | bisphosphonates | Kidney Disease: Improving Global Outcomes (KDIGO) | pharmacologic treatment | Metabolic bone disease | BONE-MINERAL DENSITY | RENAL-FUNCTION | CALCIUM SUPPLEMENTATION | NANDROLONE DECANOATE | UROLOGY & NEPHROLOGY | QUANTITATIVE ULTRASOUND | CHRONIC KIDNEY-DISEASE | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | POSTMENOPAUSAL WOMEN | ESTABLISHED OSTEOPOROSIS | Life Style | Raloxifene Hydrochloride - therapeutic use | Teriparatide - therapeutic use | Bone Density - physiology | Osteoporosis - therapy | Humans | Vitamin D Deficiency - drug therapy | Tomography, X-Ray Computed - methods | Calcitonin - therapeutic use | Parathyroid Hormone - blood | Vitamin D Deficiency - physiopathology | Glomerular Filtration Rate - physiology | Calcitonin - administration & dosage | Renal Insufficiency, Chronic - epidemiology | Accidental Falls - prevention & control | Selective Estrogen Receptor Modulators - therapeutic use | Nandrolone - therapeutic use | Diphosphonates - therapeutic use | Phosphates - blood | Female | Osteoporosis - physiopathology | Osteoporosis - epidemiology | Parathyroid Hormone - physiology | Teriparatide - administration & dosage | Comorbidity | Nandrolone - administration & dosage | Nandrolone - analogs & derivatives | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - administration & dosage | Nitric Oxide - administration & dosage | Absorptiometry, Photon | Renal Insufficiency, Chronic - physiopathology | Magnetic Resonance Imaging | Animals | Vitamin D Deficiency - epidemiology | Aged | Muscle Strength - physiology
Journal Article